Asia Pacific Diabetes Treatment Market Research Report – Segmented By Drug Class (Insulin DPP-4, Inhibitors GLP-1, Receptor Agonists, SGLT2 Inhibitors), Diabetes Type, Distribution Channel & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) – Industry Analysis From 2026 to 2034